Johnson & Johnson (JNJ) has finally broken out on the upside. Prices are retesting the highs established back in 2017 and 2018. Let's check out our favorite set of charts and indicators to see how this pharma powerhouse can climb in the first quarter of 2020.
More from Investing
The Disney+ effect, regional subscriber growth and 2020 content spending and free cash flow guidance are among the things to track as the streaming giant reports.
Charts are far more valuable as a tool for trade and portfolio management.
Trying to fight the positive trend has been a disaster for the naysayers.
Last year wasn't particularly kind to every stock, but some are turning around for the better in 2020.